Despite the importance of pretransplantation outcomes, 1-year posttransplantation survival is typically considered the primary metric of lung transplant center performance in the United States. We designed a novel lung transplant center performance metric that incorporates both pre-and posttransplantation survival time. We performed an ecologic study of 12 187 lung transplant candidates listed at 56 U.S. lung transplant centers between 2006 and 2012. We calculated an "intention-to-treat" survival (ITTS) metric as the percentage of waiting list candidates surviving at least 1 year after transplantation. The median center-level 1-year posttransplantation survival rate was 84.1%, and the median center-level ITTS was 66.9% (mean absolute difference 19.6%, 95% limits of agreement 4.3 to 35.1%). All but 10 centers had ITTS values that were significantly lower than 1-year posttransplantation survival rates. Observed ITTS was significantly lower than expected ITTS for 7 centers. These data show that one third of lung transplant candidates do not survive 1 year after transplantation, and that 12% of centers have lower than expected ITTS. An "intention-to-treat" survival metric may provide a more realistic expectation of patient outcomes at transplant centers and may be of value to transplant centers and policymakers.
K E Y W O R D S
health services and outcomes research, lung transplantation/pulmonology, patient survival, registry/registry analysis, waitlist management Although the PSRs contain many performance metrics, none combines both pre-and posttransplantation survival time. Patients are unlikely to be able to integrate transplantation rates, waiting list mortality rates, posttransplantation survival rates, and transplant center volume in order to choose the center that maximizes their chances of achieving a good outcome, which may reasonably include both successful transplantation and survival 1 year after transplantation. To provide a more transparent, meaningful, and comprehensive measure of lung transplant center performance, we developed a novel, patient-centered "intentionto-treat" measure that incorporates both the probability of transplantation and the probability of patient survival 1 year after transplantation, which we term "intention-to-treat" survival (ITTS). We hypothesized that ITTS would significantly and substantially underestimate 1-year posttransplantation survival rates at most lung transplant centers, and that variation in ITTS across centers would not be entirely explained by the characteristics of the waiting list candidates at each center.
| MATERIALS AND METHODS

| Study design, participants, and data sources
We performed an ecologic study of lung transplant candidates placed on the active waiting list between January 1, 2006 and December
31, 2012 based on Organ Procurement and Transplantation Network
(OPTN) data as of September 9, 2016 . Of the 15 913 listed candidates at 68 centers during the study period, we excluded those with follow-up time of less than 1 year after transplantation (n = 273), retransplant candidates (n = 2047), those who were simultaneously listed at multiple centers (n = 284), candidates at centers that only listed one candidate (n = 1), and those removed for the following reasons: refused transplantation (n = 70), transferred to another center (n = 44), "other" (n = 573), condition improved (n = 203), transplanted at another center (n = 81), living donor transplantation (n = 2), candidate removed in error (n = 14), and unable to contact candidate (n = 27), leaving 12 294 candidates at 68 centers. After generating the expected ITTS prediction model described below, we further excluded 12 of the 68 centers that had fewer than 20 expected ITTS events to avoid overinterpretation of the performance of low volume centers and to permit inferential statistical hypothesis testing. These 12 centers listed 23 or fewer candidates each during the study period (n = 107 candidates in total). This left 12 187 candidates who were included in the study. The Columbia University Medical Center Institutional Review Board approved this study (IRB #AAAB5142).
| Measurements
We calculated the ITTS as the number of waiting candidates who both underwent transplantation and survived at least 1 year after transplantation divided by the number of waiting list candidates placed on the list during the study period multiplied by 100. For example, a transplant center that listed 1000 patients during the study period, of whom 700 were transplanted and of whom 650 survived through 1 year would have an ITTS of 650 ÷ 1000 × 100, or 65%. This same center would have a 1-year posttransplantation survival of 650 ÷ 700 × 100, or 93%.
| Analysis approach
Candidate characteristics were summarized by means and percentages across quartiles of ITTS. We used a Pearson correlation coefficient to examine the correlation between center-level 1-year survival and ITTS.
To examine patient expectations of center performance, we compared the survival rate that patients expect to experience at each center (1-year posttransplantation survival, hereafter termed "anticipated" survival) to the observed survival that patients experience at each center (observed ITTS) by calculating the raw observed-to-"anticipated"
(O/A) ratio for each center. Standard errors and chi-square statistics were calculated for each center's O/A survival to generate 95% confidence intervals (CIs). We also calculated the absolute differences between observed and anticipated survival, which we refer to as the "discrepancy" between observed and anticipated survival.
To compare observed and expected ITTS, we used the glmnet package in R to develop a prediction model for expected ITTS using penalized estimation and shrinkage (least absolute shrinkage and selection operator, LASSO) with 10-fold cross-validation. 
| RESULTS
| Baseline characteristics
We studied 12 187 candidates placed on the waiting list at 56 lung transplant centers during the study period, of whom 10 129 underwent transplantation (1486 of whom died within 1 year of transplantation), 1235 died on the waiting list, and 823 were removed from the list because of clinical deterioration or medical instability. The mean age at listing was 54.5 years, 43% were women, and the mean LAS at listing was 40.0. Bilateral transplantation tended to be more common among centers with higher ITTS (Table 1) . Other candidate, donor, and recipient characteristics were similar across centers with high and low ITTS and posttransplantation survival rates (Tables 1   and 2 ).
| "Intention-to-treat" and posttransplantation survival
The median center-level 1-year posttransplantation survival rate was 84.1%, and the median center-level ITTS was 66.9%, indicating that one third of adult lung transplant candidates never achieved 1-year survival after lung transplantation. Center-level ITTS correlated with the center-level 1-year posttransplantation survival rate (r = 0.58, P < .001).
On average, there was a large discrepancy (absolute difference)
between ITTS and 1-year posttransplantation survival. ITTS underestimated 1-year posttransplantation survival rate by a mean absolute difference of 19.6% (95% limits of agreement 4.1% to 35.1%). were significantly lower than the survival rate anticipated by patients. Figure 2B shows the O/E ratio for each center with 95% CIs.
Although there was wide variation in O/E ratios (most centers falling between 0.75 and 1.25), only 7 centers had an O/E ratio significantly less than 1, indicating worse than expected ITTS. Two centers had an O/E ratio significantly greater than 1 (better than expected ITTS).
After controlling for patient-level factors, 57% of ITTS variability was attributable to variation across centers.
| DISCUSSION
We found that a simple measure that incorporates both pre-and The SRTR publishes PSRs biannually for each organ-specific program at each center. PSRs serve an important role in informing performance improvement efforts and program accreditation, while at the same time the public availability of these reports can sway patients, providers, and third-party payers when selecting transplant centers. 5 The methodology used to generate PSRs was publically reviewed and critiqued in 2012, 3 and has gradually undergone revision, 6 yet PSRs do not currently include a metric that combines both pre-and posttransplantation survival. If included in PSRs, the ITTS, or a similar "intention-to-treat" metric, would provide new information not currently available to patients that could transform the way patients perceive lung transplant center performance.
We found that center-specific 1-year posttransplantation survival rates significantly overestimate ITTS by 20% on an absolute scale, with over 80% of program ITTS values differing significantly from their posttransplantation survival rates. Notably, we found that this discrepancy was greatest among centers with either high or low posttransplantation survival rates, and least among mid-performing centers.
The magnitude of the discrepancies at higher performing centers and the similarities of the ITTS among high and mid-performing centers suggest that, on average, overall patient outcomes at centers with F I G U R E 1 One-year posttransplantation survival (black bars), expected "intention-to-treat" survival (dark gray bars), and observed "intention-to-treat" survival (light gray bars) for (A) the 10 centers with the highest posttransplantation survival rates, (B) the 10 centers with mid-range posttransplantation survival rates, and (C) the 10 centers with the lowest posttransplantation survival rates. Numbers along the x-axis represent each center's posttransplantation survival rank from highest to lowest cause not all participants in our study underwent transplantation, our F I G U R E 2 A, "Observed-to-anticipated" (O/A) survival ratio for each center (black squares) and 95% confidence intervals (horizontal lines). Observed survival is "intention-to-treat" survival. Anticipated survival is 1-year posttransplantation survival. Centers with confidence intervals that exclude a value of 1 (the vertical line) have "intention-to-treat" survival rates that are significantly different from "anticipated." B, "Observed-to-expected" (O/E) survival for each center (black squared) and 95% confidence intervals (horizontal lines). Observed survival is "intention-to-treat" survival. Expected "intention-to-treat" survival is based on a risk prediction model that includes candidate characteristics. Centers with confidence intervals that excludes a value of 1 (the vertical line) have "intention-to-treat" survival rates that are significantly different from "expected" In summary, we describe a new metric of lung transplant center performance that captures both pre-and posttransplantation survival after lung transplantation. This more inclusive center-specific measure has the potential to provide critical information to patients and may ultimately be found to help transplant centers focus on improving the outcomes of all patients with advanced lung diseases. 
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